Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| ID | DOID:2999 |
| Name | granulosa cell tumor |
| Definition | A sex cord-gonadal stromal tumor that has_material_basis_in granulosa cells and arises from the sex cord stroma. |
| Source | DiseaseOntology.org |
| Alt Ids | DOID:5333 |
| Path | disease disease of cellular proliferation cancer organ system cancer reproductive organ cancer sex cord-gonadal stromal tumor granulosa cell tumor |
| Molecular Profile | Therapy | Indication/Tumor Type | Response Type | Profile Response Detail |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT01851369 | Phase Ib/II | Temozolomide + TRC102 | TRC102 and Temozolomide for Relapsed Solid Tumors and Lymphomas | Completed | USA | 0 |
| NCT03909152 | Phase II | Onapristone Anastrozole + Onapristone | A Study of Onapristone ER Alone Or In Combination With Anastrozole in Gynecologic Cancers That Respond to Progesterone | Completed | USA | 0 |
| NCT03926936 | Phase II | Fulvestrant | FUlvestrant in Gynecological Cancers That Are Potentially Hormone Sensitive: the FUCHSia Study (FUCHSia) | Completed | NLD | BEL | 0 |
| NCT05348356 | Phase II | Nirogacestat | Nirogacestat in Ovarian Granulosa Cell Tumors | Active, not recruiting | USA | POL | CAN | 0 |
| NCT05872204 | Phase II | Abemaciclib + Letrozole | Abemaciclib and Letrozole in Patients With Estrogen Receptor-positive Rare Ovarian Cancer (ALEPRO) | Recruiting | NLD | FRA | BEL | 0 |
| NCT06169124 | Phase II | Darolutamide + Exemestane + Leuprolide | Study to Test the Drug Darolutamide Along With the Drugs Leuprolide Acetate and Exemestane in Patients With Recurrent Ovarian Granulosa Cell Tumors | Active, not recruiting | USA | 0 |
| NCT06638931 | Phase II | Nivolumab | Agnostic Therapy in Rare Solid Tumors (ANTARES) | Active, not recruiting | BRA | 0 |